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Introduction
Adhesive capsulitis or frozen shoulder is characterised by
painful stiffness of the shoulder that may persist for several
years. It is a common disorder, with an estimated annual
incidence of 3% to 5% in the general population (Bridgman
1972, Pal et al 1986). Advocated treatments include rest and
analgesics, corticosteroid injections, acupuncture, physical
therapy, manipulation under anaesthesia, and arthroscopic or
open surgery. There is no general acceptance of one standard
treatment (Green et al 2000).
Economic evaluations can provide useful information to
support medical decisions and the allocation of health care
resources (Haas 2003), but so far no economic evaluations of
adhesive capsulitis or its treatments have been published.
Some studies do claim that a particular treatment is cost-
effective, but they do so without actually analysing costs
(Ekelund and Rydell 1992, Fareed and Gallivan 1989). Some
studies report on return to work, but without estimating the
associated costs (Andersen et al 1998, Griggs et al 2000,
Weber et al 1995).
Our study compared high-grade and low-grade mobilisation
techniques (also known as end-range and mid-range
mobilisation techniques) in the treatment of adhesive
capsulitis. Clinical comparison (Vermeulen et al under
review) showed that in both groups patients improved
significantly. After three months, 87% of the patients in both
the high-grade mobilisation and the low-grade mobilisation
groups reported improved or much improved shoulder
function. In general, the improvements were somewhat
greater in the high-grade mobilisation than in the low-grade
mobilisation group, with statistically significant differences
in passive abduction (at 3 and 12 months), active external
rotation (at 12 months), passive external rotation (total
period), and shoulder disability (total period) measured using
both the Shoulder Rating Questionnaire (Vermeulen et al
2005) and the Shoulder Disability Questionnaire (van der
Heijden et al 2000). Moreover, patients in the high-grade
mobilisation techniques group required fewer treatment
sessions.
The current paper contains two different types of economic
analyses for adhesive capsulitis. First, a cost-utility analysis is
presented, comparing high-grade and low-grade mobilisation
techniques with respect to societal costs and quality-adjusted
life years. Next, a burden-of-illness study is presented,
estimating the impact of adhesive capsulitis on costs and
health.
Method
The economic evaluation was carried out alongside a
randomised controlled trial, whose design and clinical results
are described in detail elsewhere (Vermeulen et al under
review). To compare both interventions reliably on the
primary outcome measure of improvement in active
abduction at three months, a required sample size of at least
90 patients was estimated. Between August 1999 and January
2002, 100 patients who suffered from unilateral adhesive
capsulitis for at least three months, and who experienced at
least a 50% decrease of passive joint mobility, were enrolled
in the study (Table 1).
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Patients were referred to the Department of Physical Therapy
of the Leiden University Medical Center by orthopaedists
from the Leiden University Medical Center or from four
regional non-university hospitals. Randomisation was
concealed after the baseline assessments; an administrative
assistant allocated the eligible patients to high-grade
mobilisation or low-grade mobilisation according to a
computer-generated permutated-blocks randomisation
scheme, with stratification for the presence of diabetes
mellitus and for joint capacity, measured by arthrography (≤
15 cc or > 15 cc). The local Medical Ethics Committee
approved the protocol and all patients gave written informed
consent.
Intervention  In the high-grade mobilisation group
mobilisation techniques (Grade III–IV) were used, as
described by Kaltenborn and Maitland (Kaltenborn 1976,
Maitland 1983, Vermeulen et al 2000, Vermeulen et al under
review). These mobilisation techniques are performed in the
end-ranges of the limited joint mobility of the shoulder and
are intended to influence the capsular adhesions, treat the
stiffness, and subsequently increase the joint mobility. The
duration of prolonged stress on the shoulder capsule in the
end-range position varied according to the patient’s tolerance.
In the low-grade mobilisation techniques group the therapist
informed the patients explicitly that all techniques should be
performed without causing pain in the shoulder (Grade II).
In both groups patients were treated twice weekly for 30
minutes during a period of 12 weeks and were encouraged to
attend all treatment sessions. From six weeks onward,
treatment could be reduced in frequency, or stopped, if the
therapist noticed a normal range of motion in the shoulder,
compared to the unaffected side.
Assessment of costs  Societal costs during the one-year
follow-up period were assessed in accordance with current
guidelines for economic evaluations (Gold et al 1996). Costs
are reported as undiscounted annual costs, converted to price
level 2004 Euros using the price index rate for the Dutch
health care sector (obtained from Statistics Netherlands,
www.cbs.nl). Euros can be converted to US Dollars using the
Dutch purchasing power parity index for 2004: €1 = $1.09
(www.oecd.org).
To assess the costs of the mobilisation techniques, the number
of sessions of the initial mobilisation techniques was obtained
from the study registration. The societal costs per session
were estimated at €36 per session, which includes the
standard Dutch reimbursement for individual physical
therapy of €22 per session (www.ctg-zaio.nl). This tariff is
based on standard annual wages and on practice costs,
divided over 16 sessions per day and 230 working days per
year. As many physical therapists obtain their entire income
from this tariff, it is a reasonable reflection of the true costs of
physical therapy. The societal costs per session further
include time and travel costs incurred by the patient. Time
costs were estimated at 1 hour valued at €10 (van den Berg
et al 2005). Based on an average travelling distance of 5 km,
travel costs were estimated at €4.
Health care due to adhesive capsulitis prior to the study
period was reported retrospectively by the patients at
baseline. All health care during the study period was reported
by the patients using quarterly cost questionnaires. Health
care was valued according to Dutch standard prices that were
designed to reflect societal costs and to standardise economic
evaluations (Oostenbrink et al 2002) or, if standard prices
were not available, charges were used (www.ctg-zaio.nl). All
prices include time and travel costs (Nyman 2004), based on
national averages. The prices per session or consultation
ranged from €3 for hydrotherapy (Patrick et al 2001) to €78,
on average, for alternative medicine. Hospitalisations were
valued at €351 and €457 per day for general and university
hospitals respectively, plus, on average, €818 per
hospitalisation for specialist care and physical therapy.
Hospitalisations for treatment of the affected shoulder were
classified as due to adhesive capsulitis, which included
manipulation under general anaesthesia and acromioplasty.
Home nursing care was valued at €35 per hour. Purchased
medication was valued according to the Pharmacotherapeutic
Compass (www.fk.cvz.nl), plus €7 for each purchase other
than over-the-counter medications.
Non-health care costs were also reported by the patients in the
quarterly cost questionnaires. Expenses due to adhesive
capsulitis were valued as reported by the patients. Patients in
paid labour reported in detail on hours of absenteeism and
also how many days’ work they would need to make up for
inefficiency during the days they were not absent. Both
absenteeism and inefficiency were valued using the patient’s
gross income per hour. Time spent on unpaid labour (van
Roijen et al 1996) was compared to the age and gender
specific average over the entire sample, and the difference
was valued at €10 (van den Berg et al 2005). Using this
method, patients who reported more unpaid labour than
average have negative costs (profits). Domestic help was
valued at €20 per hour, and reported informal care at €10,
with a maximum of 28 hours per week (van den Berg et al
2005).
Assessments of utility and quality adjusted life years  Utility
is the valuation of the health of the patient (Torrance 1986),
on a scale from zero (as bad as death) to one (as good as full
health). Patients described their general health status using
the Short-Form 36-Item Health Survey (SF-36) (Ware and
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Table 1. Inclusion and exclusion criteria.
Inclusion criteria
• Unilateral adhesive capsulitis, defined as more than
50% loss of passive movement of the shoulder joint
compared to the non-affected side, in one or more of
three movement directions (i.e. abduction in the frontal
plane and/or forward flexion and/or external rotation in 0
degrees abduction)
• At least three months of complaints
• Ability to complete questionnaires in Dutch.
Exclusion criteria
• Former manipulation under anaesthesia of the affected
shoulder
• Rheumatoid arthritis, osteoarthritis, damage of the
glenohumeral cartilage, Hill-Sachs lesion, osteoporosis,
or malignancies in the shoulder region
• Neurological deficits affecting shoulder function in
activities of daily living
• Pain and/or disorders of the cervical spine, elbow, wrist
and/or hand
• An injection with corticosteroids in the affected shoulder
in the preceding four weeks.
Gandek 1998). The SF-36 consists of 36 items on physical
and social functioning, role limitations, mental health,
vitality, pain, and perception of general health. From the 
SF-36, the Short Form 6D (SF-6D) utility index was
calculated (Brazier et al 2002). This utility index reflects how
the general public values the health status described by the
patient; this type of appraisal is preferred for economic
evaluations from a societal perspective.
The influence of separate domains of the SF-6D was analysed
by replacing the responses to all other domains with the best
possible response. Because the SF-6D utility scoring function
is non-additive in the separate domains, the losses due to the
separate domains do not add up to the total utility loss.
Quality adjusted life years (QALYs) were calculated as the
area under the utility curve. A year lived in full health
corresponds with 1.0 QALY, whereas, for example, a year in
which utility linearly increases from 0.6 to 0.8 represents 0.7
QALY, that is 0.3 QALY loss compared to full health. QALYs
aim to be a measure capturing the two central goals of health
care: prolonging life and improving health. As a result it is the
preferred measure for economic evaluations, allowing for
comparison of diverse treatments and patient groups.
Analysis  Patients were evaluated according to intention-to-
treat. Fifteen cost questionnaires (4.1%) from 13 different
patients and one SF-6D measurement (0.3%) were missing.
Missing measurements were imputed by carrying forward the
previous available measurement.
For all outcome measures, differences were tested using
double-sided non-parametric bootstrapping (Desgagne et al
1998), with 1 000 000 replications and 0.05 significance
threshold. Reported confidence intervals (CIs) are the
corresponding asymmetric 95% trimmed intervals.
Bootstrapping explicitly compares the means in both groups,
without making distributional assumptions, thus allowing for
skewed distributed costs.
The cost-utility analysis estimates differences between high-
grade and low-grade mobilisation techniques, whereas the
burden-of-illness study estimates the impact of adhesive
capsulitis, irrespective of randomisation. Burden attributable
to a particular illness is usually estimated by comparing
individuals who have that illness to individuals who do not.
For adhesive capsulitis this method cannot be used, because
patients frequently have coexisting diseases of which the
burden would unjustly be attributed to adhesive capsulitis.
Instead, because adhesive capsulitis is a temporary disease,
the final fourth quarter was used to estimate burden in the
absence of adhesive capsulitis, except for cost items that were
explicitly recorded as attributable to adhesive capsulitis. If C1
denotes costs in the i-th quarter (i = 1..4), then the attributable
costs are estimated by (C1-C4) + (C2-C4) + (C3-C4), i.e. the
annual costs minus four times the costs during the fourth
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Table 2. Baseline characteristics* of included patients (n = 92).
High-grade mobilisation Low-grade mobilisation p value†
techniques techniques
Randomised patients 49 51
Included patients 44 48 0.48
General characteristics
Age, in years 51 (47–56) 51 (45–57) 0.92
Female 29 (66%) 33 (69%) 0.83
Educational level: low/secondary/high 16/17/11 14/22/12 0.72
Paid employment 31 (70%) 32 (67%) 0.82
Working hours per week‡ 32 (19–40) 34 (23–40) 0.72
Disease characteristics
Dominant shoulder affected 20 (45%) 29 (60%) 0.21
Duration of complaints (months) 8 (5–12) 9 (6–15) 0.35
Diabetes mellitus 7 (16%) 8 (17%) 1.00
Other chronic diseases 7 (16%) 11 (23%) 0.44
Prior treatment of adhesive capsulitis
No prior treatment 0 (0%) 2 (4%) 0.50
Pain medication at baseline 17 (39%) 19 (40%) 1.00
Shoulder injections 28 (64%) 28 (58%) 0.67
Number of shoulder injections‡ 2 (1–3) 3 (1–5) 0.62
Acupuncture 3 (7%) 1 (2%) 0.50
Physical therapy 34 (77%) 40 (83%) 0.60
Number of physical therapy sessions‡ 15 (9–28) 19 (12–38) 0.15
Surgery 2 (5%) 3 (6%) 1.00
*Measures show either the number of patients (with percentage), or the median (with interquartile range). †Mann-Whitney U test,
Pearson chi-square test or Fisher’s exact test, where appropriate. ‡Among those with non-zero values.
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quarter. If the burden due to adhesive capsulitis during the
fourth quarter is still substantial, then the burden without
adhesive capsulitis will be overestimated and that attributed
to adhesive capsulitis will be underestimated.
Results
Of the 100 randomised patients, the initial four were excluded
from the economic evaluation because, for logistical reasons,
they were unable to fill out the initial cost questionnaire. Four
more patients withdrew from the study without follow-up.
Table 2 shows the baseline characteristics of the included 92
patients. There were no statistically significant differences
between both randomisation groups (p ≥ 0.15). Also, the eight
excluded patients did not differ significantly from the
included patients (p ≥ 0.11, data not shown).
Cost-utility analysis  Of all types of health care utilisation,
the only statistically significant difference between the
patients receiving the high-grade and low-grade mobilisation
techniques was the 2.9 difference in the number of sessions of
initial therapy (Table 3). The associated cost difference was
estimated at €105 in favour of high-grade mobilisation
techniques (p = 0.001, 95% CI €43 to €158), of which €64
was for the therapy itself and €41 was for time and travel
costs incurred by the patient.
Physical therapy and other physical medicine was also less
frequent in the high-grade mobilisation techniques group, but
not significantly so. The cost difference for physical medicine
is counterbalanced by non-significant differences in the other
health care categories. Hospitalisations due to adhesive
capsulitis were especially more frequent in the high-grade
Table 3. Average annual health care costs per patient, by treatment (in €).
High-grade mobilisation techniques Low-grade mobilisation techniques
Volume Costs Volume Costs p value*
Physical medicine
Mobilisation techniques 18.6 663 21.5 768 0.001
Other physical therapy 7.5 268 7.9 282 0.88
Other physical medicine 1.3 44 2.5 101 0.25
– Manual therapy 0.3 16 0.9 40 0.54
– Exercise therapy 0.1 4 0.6 22 0.24
– Chiropractic 0.3 10 1.0 39 0.42
– Hydrotherapy 0.6 13 0.0 0 0.44
Consultations
Specialists 4.5 306 5.5 219 0.30
– Orthopaedist 1.2 72 0.7 39 0.09
– Surgeon 1.0 53 0.6 34 0.41
– Internist 0.6 52 0.4 35 0.45
– Other specialist 1.7 129 3.8 111 0.78
General practitioner 4.8 160 5.9 184 0.63
Occupational physician 2.0 133 2.1 134 0.98
Paramedical professionals 1.1 67 0.9 48 0.50
– Labour expert 0.4 25 0.4 23 0.89
– Social worker 0.3 14 0.2 10 0.72
Other 0.4 28 0.2 15 0.53
Alternative medicine 0.3 23 0.4 35 0.69
Hospitalisations
Due to adhesive capsulitis 14% 260 2% 29 0.07
Other hospitalisations 16% 573 10% 370 0.52
Miscellaneous
Shoulder injections 41% 3 15% 1 0.19
Analgesics 41 16 0.11
Other medication 11 2 0.21
Medical devices 2 17 0.44
Home nursing care 0 88 0.44
Total health care costs (SD) 2552 (2182) 2293 (2198) 0.58
*Average costs in high-grade mobilisation techniques group (n = 44) versus average costs in low-grade mobilisation techniques
group (n = 48), tested using two-sided non-parametric bootstrapping.
mobilisation techniques group. The overall difference in
health care costs was estimated at €259 in favour of low-
grade mobilisation techniques (p = 0.58, 95% CI €-644 to
€1162).
All non-health care costs showed no significant difference
(Table 4). The largest observed difference was the non-
significant difference of €909 in unpaid labour in favour of
low-grade mobilisation techniques (p = 0.47, 95% CI €-1564
to €3352). The estimated overall difference in non-health
care costs was €1639 in favour of low-grade mobilisation
techniques (p = 0.41, 95% CI €-2606 to €5212). Since both
the health care and the non-health care costs were estimated
in favour of low-grade mobilisation techniques, the total
societal costs were also in favour of low-grade mobilisation
techniques. The difference was estimated at €1898, but was
not statistically significant (p = 0.37, 95% CI €-2551 to
€5711).
Utility in the high-grade and low-grade mobilisation
techniques groups did not show a considerable or statistically
significant difference (Fig. 1, Table 5). The difference was
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Table 4. Average annual societal costs per patient, by treatment (in €).
High-grade mobilisation techniques Low-grade mobilisation techniques
Volume Costs Volume Costs p value*
Productivity
Unpaid productivity 22.4 h/wk 474 24.8 h/wk -435† 0.47
Paid productivity loss 228.8 h 4555 227.7 h 4173 0.80
Among employed
– Absenteeism 240.6 h 307.5 h
– Loss due to inefficiency 64.5 h 34.0 h
Miscellaneous
Domestic care 32.0 h 628 26.0 h 510 0.64
Informal care 46.1 h 459 33.9 h 338 0.68
Out-of-pocket expenses 140 33 0.46
– Of which at work 101 17 0.46
– Of which private 39 15 0.51
Total non-health care costs (SD) 6257 (10 297) 4618 (8215) 0.41
Total societal costs (SD) 8809 (10 800) 6911 (8790) 0.37
*Average costs in high-grade mobilisation techniques group (n = 44) versus average costs in low-grade mobilisation techniques
group (n = 48), tested using two-sided non-parametric bootstrapping. †Negative costs indicate savings, due to more than average
unpaid labour.
Figure 1. Average utility, by treatment. Utility is measured
on a scale from 0.0 (as bad as death) to 1.0 (full health).
Error bars indicate 95% confidence intervals for the mean
over the entire study population.
Figure 2. Average costs, in entire sample. The shaded area
indicates the societal costs attributed to adhesive capsulitis.
Error bars indicate 95% confidence intervals for the mean
over the entire study population.
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Table 6. Costs attributable to adhesive capsulitis, in entire sample (in €).
Annual costs 4th Quarter costs Attributable costs* p value‡
Prior health care costs - - 1040† -
Physical medicine
Mobilisation techniques 718 0 718† < 0.001
Other physical therapy 276 90 -84 0.001
Other physical medicine 74 11 32 0.38
Consultations
Specialists 260 63 7 0.57
General practitioner 172 43 0 0.19
Occupational physician 134 15 74 < 0.001
Paramedical professionals 57 12 8 0.62
Alternative medicine 29 3 16 0.38
Hospitalisations
Due to adhesive capsulitis 139 27 139† 0.08
Other hospitalisations 468 69 193 0.39
Miscellaneous
Shoulder injections 2 1 2† 0.85
Analgesics 28 7 0 0.11
Other medication 6 0 4 0.30
Medical devices 9 1 7 0.44
Home nursing care 46 23 -46 0.08
Non-health care costs
Unpaid productivity loss 0 164 -655 0.04
Paid productivity loss 4356 363 2903 < 0.001
Domestic care 566 138 14 0.45
Informal care 396 83 65 0.28
Out-of-pocket expenses 84 5 84† 0.44
Total health care costs (SD) 2110 (2206) < 0.001
Total non-health care costs (SD) 2411 (7500) 0.001
Total societal costs (SD) 4521 (8090) < 0.001
*Annual costs minus four times the costs during the fourth quarter, except for cost items that were explicitly recorded as
attributable to adhesive capsulitis. †These cost items were explicitly recorded as attributable to adhesive capsulitis. ‡Average
within subject change from first to fourth quarter in total sample (n = 92) versus nil, tested using two-sided non-parametric
bootstrapping.
Table 5. Average Quality Adjusted Life Years (SD), by treatment.
High-grade mobilisation Low-grade mobilisation p value*
techniques techniques
QALYs 0.695 (0.104) 0.702 (0.091) 0.71
Loss due to
Physical functioning 0.084 (0.035) 0.087 (0.033) 0.59
Social functioning 0.039 (0.038) 0.042 (0.035) 0.71
Role limitations 0.061 (0.031) 0.046 (0.034) 0.03
Mental health 0.052 (0.024) 0.057 (0.030) 0.46
Vitality 0.011 (0.013) 0.015 (0.014) 0.16
Pain 0.076 (0.047) 0.072 (0.044) 0.66
*Average in high-grade mobilisation techniques group (n = 44) versus average in low-grade mobilisation techniques group (n =
48), tested using two-sided non-parametric bootstrapping.
estimated at only 0.007 (p = 0.71, 95% CI -032 to 0.049).
Also, the separate domains of the SF-6D showed no
significant differences (p ≥ 0.16), except that the high-grade
mobilisation techniques group reported more role limitations
(p = 0.03).
Burden-of-illness study  Over the entire sample, several
outcome measures showed statistically significant changes
during the follow-up period, suggesting a causal relationship
between adhesive capsulitis and those outcome measures.
Assuming that adhesive capsulitis is no longer a burden in the
fourth quarter, the excess burden in the first three quarters is
attributable to adhesive capsulitis. For example, the shaded
area in Figure 2 indicates the societal costs attributable to
adhesive capsulitis during the follow-up period.
The value of health care attributable to adhesive capsulitis
prior to inclusion was estimated at €1040 (Table 2 and 6,
95% CI €804 to €1211) and, together with the costs during
the study period, at €2110 (95% CI €1635 to €2547). Due to
substitution with the initial mobilisation techniques, other
physical therapy showed a statistically significant increase
over time, from €7 in the first quarter to €90 in the last. On
the other hand, costs for visits to the occupational physician
decreased significantly, from €60 to €15.
Attributable non-health care costs were estimated at €2411
(95% CI €814 to €3921). These costs consist mostly of
productivity losses. Average absenteeism among employees
considerably improved from 129 hours in the first quarter to
68, 53, and 24 hours in later quarters, which constituted 38%,
20%, 16%, and 7% of the total working time respectively.
Assuming that the hours over 24 hours per quarter are
attributable to adhesive capsulitis, the attributable
productivity costs were estimated at €2903 per patient (95%
CI €1738 to €3790). These costs were partly compensated
by unpaid labour. Possibly because absenteeism increases the
time spent at home, average unpaid labour decreased
statistically significantly from 26 hours in the first quarter to
22 hours in the last quarter. Assuming that the hours above 22
hours per week are attributable to adhesive capsulitis, the
attributable savings are estimated at €655 (95% CI €-348 to
€1675). Together with the health care costs, the estimated
total societal costs amount to €4521 per patient (95% CI
€2803 to €6152).
The average SF-6D utility improved by 0.147 (95% CI 0.119
to 0.174) during the year (Fig. 1, Table 7). The largest
improvement was observed during the initial quarter (p <
0.001). During the second quarter the improvement was not
statistically significant (p = 0.07), but during the second half-
year the improvement was again highly significant (p =
0.001). All domains of the SF-6D showed statistically
significant improvements over the year (p ≤ 0.01), except the
vitality domain (p = 0.08). The utility improvement was
mostly due to improvements in the levels of pain (33%),
physical functioning (27%), and role limitations (22%).
Improvements in these three domains were also statistically
significant during the second half-year (p ≤ 0.05).
The average number of QALYs over the entire sample was
0.697. Assuming that without adhesive capsulitis the patients
would, on average, have had the concluding 0.745 utility
throughout the entire year (Table 7), the QALY loss due to
adhesive capsulitis is estimated at 0.745-0.697 = 0.048 QALY
(p < 0.001, 95% CI 0.032 to 0.060 QALYs).
Discussion
Our study compared high-grade and low-grade mobilisation
techniques in the treatment of adhesive capsulitis. The
clinical comparison (Vermeulen et al under review) showed
that high-grade mobilisation techniques were more effective
than low-grade mobilisation techniques in regaining
glenohumeral joint mobility and improving overall function,
and also that they required less treatment sessions. The
economic evaluation presented here rendered no other
statistically significant difference than that same difference in
the number of treatment sessions: on average 18.6 for high-
grade mobilisation techniques versus 21.5 for low-grade
mobilisation techniques. Based on the current standard tariff
for individual physical therapy in The Netherlands, the
associated cost difference is €105 in favour of high-grade
mobilisation techniques, of which €64 is for the therapy itself
and €41 is for time and travel costs incurred by the patient.
For all other cost categories the differences were non-
significant, but their size was substantial and one cannot
exclude the possibility that, for example, the observed
difference in favour of low-grade mobilisation techniques in
hospitalisations due to adhesive capsulitis is indeed caused by
the difference in mobilisation techniques. Our study had
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Table 7. Average utility over time, in entire sample.
Months since randomisation p value per comparison*
0 3 6 12 0 vs 12 0 vs 3 3 vs 6 6 vs 12
SF-6D utility 0.597 0.686 0.706 0.745 < 0.001 < 0.001 0.07 < 0.001
Loss due to
Physical functioning 0.118 0.089 0.082 0.073 < 0.001 < 0.001 0.10 0.01
Social functioning 0.052 0.041 0.039 0.035 0.002 0.05 0.59 0.49
Role limitations 0.079 0.058 0.051 0.042 < 0.001 < 0.001 0.07 0.02
Mental health 0.060 0.055 0.055 0.050 0.01 0.21 0.98 0.13
Vitality 0.014 0.015 0.013 0.011 0.08 0.45 0.28 0.12
Pain 0.115 0.077 0.071 0.061 < 0.001 < 0.001 0.12 0.01
*Average within-subject change in total sample (n = 92) versus nil, tested using two-sided non-parametric bootstrapping. All
statistically significant changes are improvements.
insufficient power to reliably compare the more variable
types of costs separately. Moreover, the estimated difference
in QALYs was non-significant and small. As a result, the
economic analysis does not allow for an evidence-based
recommendation on the preferred treatment. Based on the
clinical outcome measures (Vermeulen et al under review),
high-grade mobilisation techniques are still preferred to low-
grade mobilisation techniques. The fact that most patients had
had physical therapy prior to inclusion in the study, suggests
that high-grade mobilisation techniques are also preferred to
those other types of physical therapy, but without randomised
comparison it is not possible to reliably establish the relative
performance of other treatment strategies, or even the
advantage of high-grade mobilisation techniques compared to
natural history.
Besides the economic comparison of patients receiving high-
grade or low-grade mobilisation techniques, our study also
included a burden-of-illness analysis describing the
population of patients with adhesive capsulitis as a whole.
The average valuation of health in our entire sample
improved considerably from 0.597 at baseline to 0.745 after a
year. These values are comparable to those for patients with
relatively severe (van den Hout et al 2003) and relatively mild
rheumatoid arthritis (van den Hout et al 2005), respectively.
Clearly, after a year the valuation of health was still far from
optimal. This is, in part, due to residual adhesive capsulitis,
since 9% to 18% of the patients still indicated an impaired
shoulder function to some extent (Vermeulen et al under
review). However, the reported seven per cent absenteeism
during the fourth quarter is somewhat comparable to
absenteeism rates in The Netherlands overall, suggesting that
for most patients adhesive capsulitis no longer provides major
problems, at least at work. It would seem that coexisting
diseases contribute to the considerable remaining burden in
this population. Besides diabetes mellitus, a variety of other
chronic diseases was reported, and most reported
hospitalisations were for reasons other than adhesive
capsulitis.
The health burden due to adhesive capsulitis was estimated at
0.048 QALY, mainly due to impairment of physical
functioning, role limitations and pain. Absenteeism decreased
from 38% of the total working time in the first quarter to
seven per cent in the fourth quarter. Societal costs due to
adhesive capsulitis were estimated at €4521 per patient, of
which 47% were health care costs and 53% were non-health
care costs. Assuming a three per cent incidence in the general
population (Bridgman 1972, Pal et al 1986), the estimated
societal costs would amount to €136 per inhabitant annually.
For the patients in our study, the estimated burden is likely to
be an underestimate, because of the implicitly assumed
negligible attributable burden in the fourth quarter and
because health burden and labour costs prior to inclusion in
the study could not be estimated. On the other hand, for the
general adhesive capsulitis population our estimates could
also overestimate the true burden if the patients enrolled in
our trial were not representative, for example because our
patients were referred by orthopaedists and may have had a
higher than average disease severity. Furthermore, the burden
in settings other than that in our study can be influenced by
differences in economic climate and treatment patterns.
Cost-of-illness and burden-of-illness studies estimate the cost
and health burden due to a particular illness and are often
used to show the importance of that illness and to justify
funding of treatment and research. Contrary to cost-utility
analyses, their usefulness for policy making is highly
debatable, because a heavy burden is not necessarily
accompanied by efficient opportunities for reduction (Byford
et al 2000, Drummond 1992, Wiseman and Mooney 1998).
We do think that the impact of adhesive capsulitis is easily
underestimated, but our main reason to report the burden-of-
illness study was to inform clinical decision-making. In our
study, the median duration of complaints prior to inclusion
was nine months, whereas after three months 87% reported
improved or much improved shoulder function. Although not
corroborated by randomised research, this does suggest that
both high-grade and low-grade mobilisation techniques were
effective in treating adhesive capsulitis. Postponing treatment
could possibly have prevented treatment for some patients,
but for most patients the disease duration would have
lengthened and the productivity costs, in particular, would
have increased accordingly. Therefore, the burden-of-illness
study indicates that those who are reluctant to initiate
effective treatment because of cost considerations should
reconsider their policy. Although adhesive capsulitis is
considered a self-limiting disease in which the symptoms will
slowly resolve after two or three years, the estimated
substantial burden, both to the patient and to society, suggests
that effective early treatment of adhesive capsulitis is
warranted in order to attempt acceleration of recovery.
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